Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
France
/
Capital Goods
/
Exosens
EXENS
Exosens
Accelerated Digitization And Expanding Defense Spending Will Spur Sensor Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
01 Aug 25
Updated
09 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
€50.50
19.8% undervalued
intrinsic discount
09 Aug
€40.50
Loading
1Y
105.4%
7D
0.2%
Author's Valuation
€50.5
19.8% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
€50.5
19.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-149m
662m
2020
2021
2022
2023
2024
2025
2026
2027
2028
Revenue €662.2m
Earnings €114.6m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
11.28%
Aerospace & Defense revenue growth rate
0.42%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.17%
Calculation
€114.57m
Earnings '28
x
33.67x
PE Ratio '28
=
€3.86b
Market Cap '28
€3.86b
Market Cap '28
/
62.19m
No. shares '28
=
€62.02
Share Price '28
€62.02
Share Price '28
Discounted to 2025 @ 7.20% p.a.
=
€50.35
Fair Value '25